EQUIPT: Evaluating Quality of life In Period Treatment
K
Kerry Hege, MD
Primary Investigator
Enrolling By Invitation
9-21 years
Female
Phase
N/A
100 participants needed
2 Locations
Brief description of study
The primary objective is to characterize the comparative effectiveness of hormonal therapy (combined oral contraceptives and progesterone methods), antifibrinolytic therapy, and intrauterine devices in the treatment of heavy
menstrual bleeding (HMB) in adolescent females with an underlying bleeding disorder.
Detailed description of study
Who is Eligible to Participate:
Natal female, with uterus present, and menstruating
Age 9-21 years
Self-reported heavy menstrual bleeding
Diagnosed bleeding disorder OR undergoing evaluation for a bleeding disorder
What is Involved:
For this study you will be asked to complete surveys at three different times, more often if you begin new medications. These surveys will ask you questions about your health, your therapy, and your menstrual cycle.
We will also look at your medical records so we can better understand your health and medical history. Surveys may be completed via email.
This study will take place at Riley Hospital for Childrenand will last for 15 months.
Compensation:
You will receive a $10 gift card after completion of the enrollment survey and an additional $10 gift card after completion of the final survey, for a total of $20 for participation in the study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: menorrhagia,von Willebrand disease,hemophilia, Riley
-
Age: Between 9 Years - 21 Years
-
Gender: Female
Inclusion Criteria:
Natal female, with uterus present, and menstruating
Age 9-21 years
Self-reported heavy menstrual bleeding
Diagnosed bleeding disorder OR undergoing evaluation for a bleeding disorder
Exclusion Criteria:
Currently pregnant or has been pregnant in the past 3 months
Bleeding disorder previously ruled out
On current menstrual suppression >12 months (known bleeding disorder) or >60 days (bleeding disorder evaluation)
Current anticoagulation treatment
Updated on
13 Sep 2024.
Study ID: 12874, PHO-EMORY-EQUIPT
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
